Implications for Managed Care Pharmacy from the 2021 and 2022 Medicare Advantage and Part D Proposed Rule

Webinar Recorded on March 23, 2020 

Download Presentation 

Join AMCP for a review of the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020. This webinar will take a deep dive into the policy provisions of importance to managed care pharmacy including pharmacy performance standards, specialty tier composition, real time benefit tools, continued implementation of opioid management programs, and more. Please join us and help inform AMCP’s comments to CMS!

View a summary of the proposed provisions. Comments to CMS on the Draft Call Letter are due on April 6, 2020. 

Speakers:

• Carrie Monks
  Director, Regulatory Affairs
  AMCP
• Ross Margulies
  Associate
  Foley Hoag LLP